KDM5A and pancreatic neoplasm: Intriguingly, we found that overexpression of KDM5A/C was associated with reduced sensitivity of pancreatic cancer cells to a variety of pancreatic cancer-targeting and chemotherapeutic drugs, such as axitinib and gemcitabine.